Clear Street’s Biote Corp. Warrant BTMDW Stock Holding History

Clear Street’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,104	Closed	–	–	1373
2022 Q2	$0	Buy	+1,104	New	+$595	﹤0.01%	1142

Other funds holding BTMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Clear Street's BTMDW Position: Q3 2022 in Review

Clear Street sold out of Biote Corp. Warrant (BTMDW) in Q3 2022, closing a stake of 1,104 shares.

Clear Street first reported a position in BTMDW in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 43 funds tracked by Wall St. Rank hold BTMDW as of Q3 2022.

Clear Street reported no remaining Biote Corp. Warrant position as of Q3 2022 after selling out during the quarter.
Clear Street sold 1,104 Biote Corp. Warrant shares in Q3 2022.
Clear Street first reported a position in Biote Corp. Warrant in Q2 2022 and held it in 1 quarter.
Clear Street's Biote Corp. Warrant position peaked at $0 in Q2 2022.
43 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q3 2022.

Based on Clear Street's 13F filing for Q3 2022, filed 2 Nov 2022.